Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
baseline, Chamber, closeout, Cole, Commerce, Conference, degrading, encompassed, equal, hematologic, highest, idiopathic, IIIA, investor, Lengerich, marker, microglial, month, Nat, neuroaxonal, Neurofilament, Neurosci, NfL, proven, readout, resignation, resurgence, revise, Sanfilippo, serum, SGSH, sulfohydrolase, symptomatic, unconstitutional, van, window
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view